Helix Therapeutics Garners $2,500,000 New Round

  • Feed Type
  • Date
    11/23/2010
  • Company Name
    Helix Therapeutics
  • Mailing Address
    150 Munson Street 25 Science Park 2nd Floor New Haven, CT 06511
  • Company Description
    The company is developing DNA therapeutics that will cause a paradigm shift in the way that common genetic diseases are treated…by permanently curing them.
  • Website
    http://www.helixtherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    According to Helix officials, the new funds will be used to move forward its proprietary targeted gene modification (TGM) technology platform.
  • M&A Terms
  • Venture Investor
    Canaan Partners
  • Venture Investor
    Connecticut Innovations

Trending on Xconomy